High Surgical Risk Aortic Regurgitation: New TAVR Alternatives
We Recommend
Disclosures
Within the last 24 months, I have had financial relationship(s) with the ineligible company or companies listed below:
- Consultant Fee/Honoraria/Speaker's Bureau - Abbott Vascular; Siemens Healthineers
- Institutional Grant Support - Edwards Lifesciences; Medtronic
- Grant Support/Research Contract - JenaValve